{
  "organization": {
    "name": "Pharos Capital Group",
    "legal_name": "Pharos Capital Group LLC",
    "founded": 1998,
    "headquarters": ["Dallas, TX", "Nashville, TN"],
    "type": "Private Equity Firm",
    "focus": "Healthcare Middle-Market",
    "aum": "$1 billion",
    "funds": 6,
    "total_investments": 58,
    "exits": 12,
    "current_portfolio": 9,
    "mission": "Investing in companies aimed at lowering costs, improving patient outcomes, expanding access to care",
    "target_markets": "Underserved regions",
    "website": "https://www.pharosfunds.com/",
    "sec_crd": "316789",
    "federal_lobbying": "Active registration"
  },
  "key_personnel": {
    "founder_ceo": {
      "name": "Dr. Kneeland Youngblood",
      "title": "Founder and Managing Partner",
      "age": 69,
      "education": [
        "Princeton University - B.A. in Politics",
        "University of Texas Southwestern Medical School - M.D."
      ],
      "background": "Emergency room physician at Baylor University Medical Center and Medical Center of Plano",
      "heritage": "Descendant of freed slaves",
      "legal_activity": "Sued ConocoPhillips for $900 million claiming family oil-rich land in Texas",
      "recognition": "Forbes BLK50 2024 - #50 most powerful Black Americans"
    },
    "cio": {
      "name": "Bob Crants",
      "title": "Chief Investment Officer",
      "background": "Goldman Sachs experience"
    },
    "cfo_cco": {
      "name": "Kimberly Futrell",
      "title": "Chief Compliance Officer and Chief Financial Officer"
    }
  },
  "team_structure": {
    "total_professionals": 16,
    "leadership_roles": ["Founder/Managing Partner", "Chief Investment Officer", "Chief Compliance Officer/CFO"],
    "organizational_focus": "Physician-founded approach to healthcare investing"
  },
  "portfolio_companies": {
    "current_investments": [
      "Renal Care 360 - Chronic kidney care management platform (2022)",
      "RhythMedix - Healthcare technology (2024 majority investment)"
    ],
    "investment_thesis": "Companies focused on underserved markets, cost reduction, patient outcomes improvement"
  },
  "board_positions": {
    "kneeland_youngblood": [
      "Government relations experience",
      "Medical industry board positions"
    ]
  },
  "industry_associations": {
    "milken_institute": "Panel participant - Private Equity and Patient Care: A Delicate Balancing Act",
    "sec_compliance": "Uses Ontra AI-powered compliance platform",
    "professional_networks": "Healthcare private equity industry leadership"
  },
  "regulatory_status": {
    "sec_registration": "Active SEC registration (CRD 316789)",
    "compliance_record": "Clean regulatory record - no SEC issues or fraud allegations",
    "lobbying_registration": "Active federal lobbying registration",
    "compliance_technology": "Ontra Insight platform - 40 hours saved in SEC exam response"
  },
  "recognition": {
    "forbes_blk50_2024": {
      "ranking": 50,
      "category": "Most powerful, impactful, and wealthiest Black Americans",
      "criteria": "Social impact, social media presence, company status, title/position, net worth"
    },
    "milken_institute_participation": "28th Annual Global Conference panel on healthcare PE ethics"
  }
}